Vés al contingut

Inflammation and Chronic Disease

25 jun 07

Barcelona, Spain. 25 - 27 June, 2007 A BBVA Foundation and IRB Barcelona conference that will provide an interdisciplinary forum for scientific investigators interested in the cellular and molecular mechanisms of the inflammatory/innate immune response.

Imatge

Presentation

The Barcelona BioMed Conference on Inflammation and Chronic Disease will be held in Barcelona, Spain, on the 25 - 27 June 2007.

Inflammation causes a large number of chronic diseases including rheumatoid arthritis, psoriasis, multiple sclerosis, inflammatory bowel disease and chronic obstructive pulmonary disease.  In addition, considerable evidence indicates that inflammation is at the origin of other diseases including cancer and certain cardiovascular and metabolic diseases, such as atherosclerosis and type 2 diabetes, respectively.

These diseases are slowly disabling or fatal and affect a high percentage of the population. Current research efforts focus on dissecting the molecular and cellular mechanisms behind the inflammatory response in order to provide an extensive array of targets for the development of anti-inflammatory drugs.

The conference will provide an interdisciplinary forum for scientific investigators interested in the cellular and molecular mechanisms of the inflammatory/innate immune response and their involvement in the development of chronic inflammatory diseases.

Barcelona BioMed conferences bring together about 20 speakers, selected from among leading international researchers, in a highly focused think-tank atmosphere. An additional 40 participants, selected on the basis of their scientific experience, are invited to join.

Registration deadline: 30 April 2007

Organizer:
IRB Barcelona with the collaboration of the Banco Bilbao Vizcaya Argentaria Foundation (FBBVA).

Hosted by the Institut d'Estudis Catalans (IEC).

For more information, please contact the Barcelona BioMed Conference Secretariat at
biomedirbbarcelona.org

There is no registration fee, but the number of participants is limited; participants will be selected according to scientific merit.

Those interested in participating should fill out the registration form and attach a short CV, indicating the most relevant publications, and a brief description of their current research.

Participant interested in submitting an abstract for a poster session (Max. 30 lines) are encouraged to do so. A few abstracts may be selected for an oral presentation.

Localització

The BARCELONA BIOMED CONFERENCE on INFLAMMATION AND CHRONIC DISEASE will be hosted by the Institut d'Estudis Catalans (IEC) in the heart of downtown Barcelona. Talks will take place in the Sala Prat de Riba.

Institut d'Estudis Catalans
C. del Carme, 47
08001 Barcelona

Tel +34 932 701 620
Fax +34 932 701 180
informacioarrobaiec.cat
www.iec.cat

mapa

How to reach the IEC by public transport:

  • metro Metro
    Plaça Catalunya (lines 1 and 3)
    Liceu (line 3)
  • ffcc FGC
    Plaça Catalunya (train from Sarrià)
  • renfe Renfe
    Plaça Catalunya
  • bus Buses
    41, 55, 141 (Plaça Catalunya stop)
    14, 18, 59, 91 (Rambla stop)

Speakers will be lodged at the Hotel Catalonia Ramblas
c/ Pelayo, 28
08001 Barcelona
Tel. +34 93.316.84.00
Fax. +34 93.316.84.01
e-mail: ramblas.comercialarrobahoteles-catalonia.es
web: www.hoteles-catalonia.com

Help in finding accommodation in Barcelona can be obtained through the following websites:

For more information about Barcelona, you can also consult the IRB Barcelona web section "Living in Barcelona".

fbbva iec

Ponents

Chairs:

  • Carme Caelles, Institute for Research in Biomedicine (Barcelona, Spain)
  • Michael Karin, University of California at San Diego (La Jolla, USA)

Invited Speakers:

  • Frances R. Balkwill, Queen Mary's Medical School (London, UK)
  • Antonio Celada, Institute for Research in Biomedicine (Barcelona,Spain)
  • Marco Colonna, Washington University School of Medicine (St. Louis, USA)  
  • Vishva M. Dixit, Genentech Inc (South San Francisco, USA)
  • Raymond N. DuBois, Vanderbilt University Medical Center (Nashville, USA)
  • Luisa Martínez Pomares, Queen’s Medical Centre (Nottingham, UK)
  • Diane Mathis, Joslin Diabetes Center (Boston, USA)
  • Danielle Melloul, Hadassah University Hospital (Jerusalem, Israel)
  • Jorge Moscat, Genome Research Institute, University of Cincinnati (Cincinnati, USA)
  • Gabriel Nuñez, University of Michigan Medical School  (Michigan, USA)
  • Bente K. Pedersen, University of Copenhagen (Copenhagen, Denmark)
  • Sven Pettersson, Karolinska Institutet (Stockholm, Sweden)
  • Steve E. Shoelson, Joslin Diabetes Center (Boston, USA)
  • Erwing F. Wagner, Research Institute of Molecular Pathology (Vienna, Austria)
  • Laurence Zitvogel, INSERM, Institut Gustave Roussy (Villejuif, France)